Medical Advocates
New and Noteworthy
 November 16, 2017

Featured Report
Clinical Management Update
Drug Update
Diagnostic/Monitoring Update
Marginalized Update
US Update
Global Update
Today's Video

Home Page

This web page is best viewed by using INTERNET EXPLORER
All Citations are abstracts UNLESS OTHERWISE NOTED
Today's Featured Report

HIV Infection/Disease

Disease Management Update
HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.

Henrich TJ, Hatano H, Bacon O, et al
PLoS Med. 2017 Nov 7;14(11):e1002417


Drug Update
  Virologic suppression and CD4 cell count recovery after initiation of raltegravir- or efavirenz- containing HIV treatment regimens.
Edwards JK, Cole SR, Hall HI, et al
AIDS. 2017 Nov 2


Raltegravir      Efavirenz

Diagnostic/Monitoring Update
  Low pre-diagnosis attrition but high pre-treatment attrition among patients with MDR-TB: An operational research from Chennai, India.
Shewade HD, Nair D, Klinton JS, et al
J Epidemiol Glob Health. 2017 Dec;7(4):227-233

Marginalized Update
  The experience of violence against children in domestic servitude in Haiti: Results from the Violence Against Children Survey, Haiti 2012.
Gilbert L, Reza A, Mercy J,
Child Abuse Negl. 2017 Nov 4;


US Update
  Factors That Influence Linkages to HIV Continuum of Care Services: Implications for Multi-Level Interventions.
Pinto RM, Witte SS, Filippone PL,
Int J Environ Res Public Health. 2017 Nov 7;14

HIV Infection/Disease

Global Update
  Factors Associated With Access to HIV Testing and Primary Care Among Migrants Living in Europe: Cross-Sectional Survey.
Fakoya I, Álvarez-Del Arco D,
JMIR Public Health Surveill. 2017 Nov 6;


HIV Infection/Disease

Today's Video

NAC Gets Youths Talking about HIV/AIDS



 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

The New and Noteworthy Web features a daily interdisciplinary focus on current journal, conference,
and video reports on clinical, political, ethical, spiritual, economic, and human rights
dimensions of life-threatening infectious diseases and violence, and the related challenges to
the marginalized affected by these diseases and behaviors.